Small Cell Lung Cancer: A New Era Is Beginning?

Small Cell Lung Cancer: A New Era Is Beginning?

Small-cell lung cancer (SCLC) is the most aggressive form of lung cancer: No significant progress has been made in finding new treatments for decades and platinum-based chemotherapy has for a long time represented the standard of care. This therapeutic scenario has recently changed, thanks to positi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Diğer Yazarlar: Morabito, Alessandro (Editör), Rolfo, Christian (Editör)
Materyal Türü: Kitap Bölümü
Baskı/Yayın Bilgisi: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
Konular:
Medicine
immune checkpoint inhibitors
extensive-stage small cell lung cancer
nivolumab
ipilimumab
pembrolizumab
atezolizumab
durvalumab
chemotherapy
small-cell lung cancer
lobectomy
pneumonectomy
radiotherapy
multimodal treatment
immunotherapy
SCLC
PARP
DDR
ICB
synthetic lethality
SLFN11
STING
pathology and classification of SCLC
biology of SCLC
immune-checkpoint inhibitors in SCLC
small cell lung cancer
Immunotherapy
extensive disease
lurbinectedin
gene pathway
pathobiology
targeted therapy
circulating tumor cells
prognostic biomarker
targeted agents
n/a
Online Erişim:Get Fullteks
DOAB: description of the publication
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

Get Fullteks
DOAB: description of the publication

3rd Floor Main Library

Detaylı Erişim Bilgileri 3rd Floor Main Library
Yer Numarası: A1234.567
Kopya Bilgisi 1 Kütüphanede

Benzer Materyaller